Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Wimmer

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Plos Pathogens|March 20, 2012
Transcriptional activation of the adenoviral genome is mediated by capsid protein VISabrina Schreiner, Ruben Martinez, Peter Groitl, et al.
Contemporary Clinical Trials|September 13, 2015
The MANDELA study: A multicenter, randomized, open-label, parallel group trial to refine the use of everolimus after heart transplantationTobias Deuse, Christoph Bara, Markus J Barten, et al.
Clinical Transplantation|May 11, 2016
Long-term follow-up of five yr shows superior renal function with everolimus plus early calcineurin inhibitor withdrawal in the PROTECT randomized liver transplantation studyMartina Sterneck, Gernot M Kaiser, Nils Heyne, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 3, 2015
Secreted frizzled-related protein 4 predicts progression of autosomal dominant polycystic kidney diseaseStefan Zschiedrich, Klemens Budde, Jens Nürnberger, et al.
Clinical Nephrology|March 3, 2016
Early conversion from cyclosporine to everolimus following living-donor kidney transplantation: outcomes at 5 years posttransplant in the randomized ZEUS trialClaudia Sommerer, Klemens Budde, Martin Zeier, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Plos Pathogens|March 20, 2012
Transcriptional activation of the adenoviral genome is mediated by capsid protein VISabrina Schreiner, Ruben Martinez, Peter Groitl, et al.
Contemporary Clinical Trials|September 13, 2015
The MANDELA study: A multicenter, randomized, open-label, parallel group trial to refine the use of everolimus after heart transplantationTobias Deuse, Christoph Bara, Markus J Barten, et al.
Clinical Transplantation|May 11, 2016
Long-term follow-up of five yr shows superior renal function with everolimus plus early calcineurin inhibitor withdrawal in the PROTECT randomized liver transplantation studyMartina Sterneck, Gernot M Kaiser, Nils Heyne, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 3, 2015
Secreted frizzled-related protein 4 predicts progression of autosomal dominant polycystic kidney diseaseStefan Zschiedrich, Klemens Budde, Jens Nürnberger, et al.
Clinical Nephrology|March 3, 2016
Early conversion from cyclosporine to everolimus following living-donor kidney transplantation: outcomes at 5 years posttransplant in the randomized ZEUS trialClaudia Sommerer, Klemens Budde, Martin Zeier, et al.
Pageof 3